The AAP recommends laboratory screening for children aged 10 years and older with obesity, including a fasting lipid panel, fasting glucose or hemoglobin A1c, and alanine aminotransferase (ALT) to assess for dyslipidemia, prediabetes/diabetes, and MAFLD, respectively [9,24]. Here, GPT is linked to obesity due to melanocortin 4 receptor deficiency.